Ha JF, Longnecker N. Doctor–patient communication: a review. Ochsner J. 2010;10:38–43.
Bredart A, Bouleuc C, Dolbeault S. Doctor–patient communication and satisfaction with care in oncology. Curr Opin Oncol. 2005;17:351–4.
Herndon JH, Pollick KJ. Continuing concerns, new challenges, and next steps in physician–patient communication. J Bone Jt Surg Am. 2002;84-A:309–15.
Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826–34.
Stewart MA. Effective physician–patient communication and health outcomes: a review. CMAJ. 1995;152:1423–33.
Duffy FD, Gordon GH, Whelan G, Cole-Kelly K, Frankel R, Buffone N, et al. Assessing competence in communication and interpersonal skills: the Kalamazoo II report. Acad Med. 2004;79:495–507.
Tongue JR, Epps HR, Forese LL. Communication skills. Instr Course Lect. 2005;54:3–9.
Taran S. An examination of the factors contributing to poor communication outside the physician–patient sphere. Mcgill J Med. 2011;13:86.
Wilson IB, Schoen C, Neuman P, Strollo MK, Rogers WH, Chang H, et al. Physician–patient communication about prescription medication nonadherence: a 50-state study of America’s seniors. J Gen Intern Med. 2007;22:6–12.
Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Prescribing new medications: a taxonomy of physician–patient communication. Commun Med. 2008;5:195–208.
Arora NK. Interacting with cancer patients: the significance of physicians’ communication behavior. Soc Sci Med. 2003;57:791–806.
McKillip RP, Borden BA, Galecki P, Ham SA, Patrick-Miller L, Hall JP, et al. Patient perceptions of care as influenced by a large institutional pharmacogenomic implementation program. Clin Pharmacol Ther 2016;102:106–114.
McKinnon RA, Ward MB, Sorich MJ. A critical analysis of barriers to the clinical implementation of pharmacogenomics. Ther Clin Risk Manag. 2007;3:751–9.
Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15:258–67.
Haga SB, Mills R, Bosworth H. Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response. Patient Educ Couns. 2014;97:10–15.
Sweet K, Sturm AC, Schmidlen T, Hovick S, Peng J, Manickam K, et al. EMR documentation of physician-patient communication following genomic counseling for actionable complex disease and pharmacogenomic results. Clin Genet. 2017;91:545–56.
Haga SB, LaPointe NM. The potential impact of pharmacogenetic testing on medication adherence. Pharm J. 2013;13:481–3.
Grant RW, Hivert M, Pandiscio JC, Florez JC, Nathan DM, Meigs JB. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. Diabetologia. 2009;52:2299–305.
Li JH, Joy SV, Haga SB, Orlando LA, Kraus WE, Ginsburg GS, et al. Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients. J Pers Med. 2014;4:147–62.
Charland SL, Agatep BC, Herrera V, Schrader B, Frueh FW, Ryvkin M, et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. Pharm J. 2014;14:272–80.
O’Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, et al. Pharmacogenomics-based point-of-care clinical decision support significantly alters drug prescribing. Clin Pharmacol Ther. 2017;102:859–69.
O’Donnell PH, Danahey K, Jacobs M, Wadhwa NR, Yuen S, Bush A, et al. Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago “1,200 Patients Project”. Am J Med Genet C. 2014;166C:68–75.
O’Donnell PH, Bush A, Spitz J, Danahey K, Saner D, Das S, et al. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther. 2012;92:446–9.
Hussain S, Kenigsberg BB, Danahey K, Lee YM, Galecki PM, Ratain MJ, et al. Disease-drug database for pharmacogenomic-based prescribing. Clin Pharmacol Ther. 2016;100:179–90.
Danahey K, Borden BA, Furner B, Yukman P, Hussain S, Saner D, et al. Simplifying the use of pharmacogenomics in clinical practice: building the genomic prescribing system. J Biomed Inform. 2017;75:110–21.
Burke W, Emery J. Genetics education for primary-care providers. Nat Rev Genet. 2002;3:561–6.
Sharp RR, Goldlust ME, Eng C. Addressing gaps in physician education using personal genomic testing. Genet Med. 2011;13:750–1.
Unertl KM, Field JR, Price L, Peterson JF. Clinician perspectives on using pharmacogenomics in clinical practice. Per Med. 2015;12:339–47.
Haga SB, Burke W, Ginsburg GS, Mills R, Agans R. Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clin Genet. 2012;82:388–94.
Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1:189–99.
Kravitz RL, Hays RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153:1869–78.
Vahdat S, Hamzehgardeshi L, Hessam S, Hamzehgardeshi Z. Patient involvement in health care decision making: a review. Iran Red Crescent Med J. 2014;16:e12454.
Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther. 2012;91:450–8.